GlobeNewswire by notified

Aino Health AB (publ): Världsledande tillverkare väljer Aino Healths SaaS-lösning HealthManager

Dela

Stockholm 30 November, 2021.

Ett världsledande tillverkningsföretag och global marknadsledare inom aggregat-, mineralbearbetnings- och metallraffineringsindustrin har valt att utöka användningen av Aino Healths SaaS-lösning HealthManager. Avtalet innehåller totalt 2 400 licenser, varav 1 300 är nya licenser. 

"Vi är mycket glada och stolta över att fortsätta och utöka en nyckelaktör inom tillverkningsindustrin som kund. Vi ser fram emot att tillsammans öka personalens välbefinnande och engagemang", säger Jyrki Eklund, VD Aino Health. 

HealthManager är Ainos egen SaaS-lösning som stödjer chefer med interna hälsorelaterade processer och frånvarohantering. Det erbjuder också rapporterings- och analysverktyg för att följa viktiga mätvärden relaterade till företagets hälsohantering. Målet med lösningen är att digitalisera arbetsförmågasprocesser och öka medarbetarnas engagemang. 


Om Aino Health (
publ)
Aino Health är den ledande leverantören av Software as a Service-lösningar inom Corporate Health Management. Företagets kompletta system med SaaS-plattformar och tjänster minskar sjukfrånvaro, sänker relaterade kostnader och förbättrar affärsresultat genom ökad produktivitet och medarbetarengagemang genom att göra hälsa, välbefinnande och säkerhet till en integrerad del av det dagliga arbetet. För mer information besök ainohealth.com. 

För mer information:

Jyrki Eklund, VD Aino Health
Telefon: +358 40 042 4221 
jyrki.eklund@ainohealth.com

Certifiedadviser
Erik Penser Bank +46 8 463 83 00 
certifiedadviser@penser.se

För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.
För att se det här innehållet från ml-eu.globenewswire.com måste du ge ditt medgivande sidans topp.

Om

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire by notified

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire by notified

Galapagos appoints Paul Stoffels as Chief Executive Officer26.1.2022 22:01:00 CET | Press release

Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirementRecognized as inspirational industry leader with exceptional R&D as well as global executive experience, and a strong focus on bringing innovative medicines to patientsOutstanding track record of accelerated product development in biotech and pharma through insightful acquisitions and strategic partnerships Mechelen, Belgium;26January 2022, 22.01CET;regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) is pleased to announce the appointment of Dr. Paul Stoffelsas Chief Executive Officer (CEO),effective April 1, 2022.Dr. Stoffelsbrings an impressive track record of success in innovative drug discovery and development,and a wealth of experience in biotech and pharma, across a range of roles and therapeutic areas. “After a rigorous selection process, we are very pleased to announce Paul as our next CEO. Given his extraordinary R&D as well as managerial experience, extensive net

XBiotech Announces First Patient Enrolled in Phase I Clinical Trial for Novel Arthritis Therapy Natrunix-SQ26.1.2022 15:50:37 CET | Press release

Natrunix-SQ, A True Human Antibody Therapy Discovered and Manufactured at XBiotech, Is Aimed as a Breakthrough Treatment for Arthritic Disease AUSTIN, Texas, Jan. 26, 2022 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) enrolled the first patient in a randomized, double-blind, placebo-controlled clinical study to evaluate safety and pharmacokinetics of Natrunix-SQ. Natrunix-SQ targets a crucial inflammatory pathway involved in pain and joint destruction in various forms of arthritis. XBiotech believes that Natrunix-SQ may be the most effective means of blocking the inflammatory pathway involved in arthritis and thus could represent a breakthrough treatment for arthritides. The Phase I study represents the launch of the clinical program for Natrunix-SQ for the treatment of rheumatological diseases. The Phase I study will evaluate Natrunix-SQ blood levels in the context of increasing doses. These findings will guide follow-up studies with Natrunix-SQ. Upon successful completion of the P

Real People Investment Holdings Limited changes its name to Evolution Credit Limited26.1.2022 14:30:00 CET | Press release

Real People Investment Holdings Limited (the "Company") has changed its name to Evolution Credit Limited. In connection with the Company's name change, the Real People group will rebrand its Real People Home Improvement Finance business to Evolution Finance and Real People Life will become Evolution Life. The rebranding will not include the debt collection business DMC Debt Management. The Company's NOK Bonds with ISIN NO0010689342 and SEK Bonds with ISIN SE0005392560 admitted to trading on Nasdaq First North Bond Market will continue to be traded under their existing short names RPIH NOK and RPIH SEK, respectively. As from 28 January 2022, the address of the Company's web page will be www.evolution.za.com. For further information, please contact: Carmen Taylor, Head of Governance and Secretarial +27 82 772 5481, carmen.taylor@evolution.za.com Attachment Real People Investment Holdings Limited - Press release re. name change

MCH Group | Ad hoc announcement pursuant to Art. 53 LR | New art fair in Paris26.1.2022 12:30:00 CET | Press release

Art Basel selected to stage new contemporary art fair in Paris MCH Group Ltd., based in Basel/Switzerland, announces that Art Basel has been awarded a seven-year contract to stage a new contemporary art fair in Paris, following a public competition initiated by the "Réunion des musées nationaux – Grand Palais" in December last year. Launching in October 2022, the new art event will take place at the temporary venue "Grand Palais Éphémère" until the restoration of the "Grand Palais" is completed in 2024. Together with the "Réunion des musées nationaux – Grand Palais", Art Basel will strive to create a fair truly rooted in the twenty-first century that radiates throughout the city and is firmly embedded in Paris and its cultural and creative industries. MCH Group intends to establish a new French legal entity and employ a dedicated team on the ground. It is planed to develop an identity and a brand specific to the Parisian fair. "City Activation is a key element in our strategy," says Be

Change to the publication time of Talenom Plc's Financial Statements Bulletin 2021: the release will be published on 8 February 2022 at 9:00 EET26.1.2022 12:00:00 CET | Press release

Talenom Plc, Press release 26 January 2022 at 13:00 EET Change to the publication time of TalenomPlc's Financial Statements Bulletin 2021: the release will be published on 8 February 2022at 9:00 EET Talenom Plc's new publication time for its Financial Statements Bulletin for 2021 is at 9:00 EET on Tuesday 8 February 2022. The previously announced time was at 13:30 EET. The company's CEO Otto-Pekka Huhtala will present the main points of the review in a live webcast on Tuesday 8 February 2022 at 10:00 EET. The live webcast will be in Finnish, but a recording of the event will be published also in English on Talenom’s website https://sijoittajat.talenom.fi/en The live webcast event can be viewed at: https://talenom.videosync.fi/tilinpaatos-2021 Participants will have the opportunity to present questions during the briefing over the webcast platform. Due to the Covid-19 situation, the event is completely virtual. The presentation materials will be published before the start of the briefin

Maha Energy announce spud of Tie-526.1.2022 12:00:00 CET | Press release

Maha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce the spud of the Tie-5 Agua Grande (AG) horizontal well in Brazil. The Tie-5 well was spudded on time as per planned schedule at 0900 (GMT-3) on January 25th on the Tie field in Brazil. The well is designed as a horizontal well and will drain the northern part of the Tie field at the Agua Grande level. As communicated earlier, the Tie-4 well was completed as a vertical producer and tested 4,695 BOEPD on an Electrical Submersible Pump (ESP). The Tie-4 well is now producing through the Tie Production Facility. Jonas Lindvall, CEO of Maha Energy comments: ”In light of the very positive well performance of Tie-4, we are very excited to start drilling the Tie-5 well. Our drilling team in Brazil have significantly improved on the Tie-4 well design and I am confident that we will be able to land the well horizontally in the AG.” Significant changes have been made to the Tie-5 well design to address the drilling issues encou

Maha Energy har påbörjat borrningen av Tie-526.1.2022 12:00:00 CET | Pressemelding

Maha Energy AB (publ) (”Maha” eller ”Bolaget”) meddelar att borrningen av Tie-5 i Brasilien har påbörjats. Borrkronan sattes i backen enligt tidplan klockan 09.00 (-3 GMT) lokal tid igår på Tiefältet i Brasilien. Planen är att Tie-5 ska bli en horisontal produktionsbrunn mot den norra delen av reservoaren Agua Grande (AG). Som tidigare kommunicerats är den vertikala Tie-4 brunnen nu kopplad till produktionsanläggningen och producerade 4 695 BOEPD1 under ett 24-timmarstest. Tie-4 färdigställdes med en elektrisk nedsänkbar pump (ESP). Jonas Lindvall, VD för Maha Energy kommenterar: ”Med tanke på det fina resultatet från Tie-4 brunnen så är vi väldigt entusiastiska över borrstarten på Tie-5. Vårt borrteam i Brasilien har gjort väsentliga förbättringar av borrplanen och jag är övertygad om att vi kommer att nå vårt mål att få ett horisontellt hål i AG-reservoaren.” De har gjorts betydande förändringar av borrplanen för Tie-5 för att undvika de problem som påträffades vid borrningen på Tie-